We are live on ! Find out more
PBM icon

Psyence Biomedical
PBM

2 hedge funds and large institutions have $575K invested in Psyence Biomedical in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

40.21% more ownership

Funds ownership: 10.32% → 50.53% (+40%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

20% less capital invested

Capital invested by funds: $718K → $575K (-$143K)

60% less funds holding

Funds holding: 5 → 2 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
2
Holders Change
-3
Holders Change %
-60%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Parallel Advisors
California
+$418K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$28K
2
Bank of America
Bank of America
North Carolina
-$2.52K
3
UBS Group
UBS Group
Switzerland
-$758
4
SFFS
Stonehage Fleming Financial Services
Jersey
-$3

PBM Hedge Fund Activity: Q1 2026 in Review

2 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q1 2026, worth a combined $575K — down 20% from $718K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PBM and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Parallel Advisors, adding an estimated $418K. The largest seller was Virtu Financial, exiting entirely with an estimated $28K sold.

  • 2 institutional investors held Psyence Biomedical (PBM) as of Q1 2026, down from 5 in Q4 2025.
  • Funds reported $575K of Psyence Biomedical stock for Q1 2026, down 20% quarter-over-quarter.
  • 0 funds opened new Psyence Biomedical positions in Q1 2026 and 3 closed out, a net change of -3 holders.
  • The largest Psyence Biomedical buyer in Q1 2026 was Parallel Advisors, an estimated $418K added.
  • The largest Psyence Biomedical seller in Q1 2026 was Virtu Financial, an estimated $28K sold.

Based on aggregated 13F filings for Q1 2026.